Arena Pharmaceuticals, Inc. (ARNA) Reports In-Line Q2 Loss of 16c/Share
Tweet Send to a FriendGet Alerts ARNA Hot Sheet
Price: $8.30 +2.98%
Financial Fact:
Total operating expenses: 23.38M
Today's EPS Names:
ANF, DXLG, FL, More
Financial Fact:
Total operating expenses: 23.38M
Today's EPS Names:
ANF, DXLG, FL, More
Trade ARNA Now!
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) reported Q2 EPS of ($0.16), in-line with the analyst estimate of ($0.16). Revenue for the quarter came in at $3.26 million versus the consensus estimate of $3.35 million.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- Nordson Corp (NDSN) Reports In-Line Q2 EPS, Q3 Guidance Falls Short
- Aeropostale, Inc. (ARO) Tops Q1 EPS by 1c; Guide for Wide Q2 Loss
Create E-mail Alert Related Categories
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
